Introduction
Cardiac computed tomography angiography (CTA) is an increasingly used non-invasive imaging method in cardiology. 1, 2 Due to the high diagnostic accuracy, coronary CTA clarifies the diagnosis of angina in patients with suspected coronary artery disease (CAD) in addition to standard clinical care 3 and coronary CTA is able to rule out CAD with high negative predictive value. 4 The improved diagnostic capabilities may alter downstream testing and clinical care in a significant proportion of patients, which may reduce cardiac events. 3, 5 Finally, coronary CTA carries significant prognostic information. 6 Radiation exposure from cardiac CTA carries the potential risk of cancer induction in a dose-dependent manner. 7 Accordingly, safety considerations of cardiac CTA are an ongoing concern and computed tomography (CT) imager should aim to reduce radiation dose exposure to be 'as low as reasonably achievable' (ALARA principle), while maintaining diagnostic image quality. 8 One decade ago, the international dose survey PROTECTION I collected data from 1965 cardiac CT studies and evaluated the radiation exposure from cardiac CTA. 9 Since then, advances in CT technology including new acquisition techniques and software algorithms, have been developed and societal guidelines as well as clinical studies have advocated for a consequent use of these techniques to lower radiation dose. [10] [11] [12] [13] [14] [15] However, the utilization and efficacy of modern techniques for radiation dose reduction in real-world clinical practice across the globe is currently unknown. Thus, the current dose survey was designed to investigate the radiation dose of cardiac CTA, the utilization and efficacy of established dose-saving strategies and the potential for further radiation dose reduction in a real-world setting in 2017.
Methods

Study protocol
The study design of the 2017 dose survey, entitled Prospective Multicenter Registry on RadiaTion Dose Estimates of Cardiac CT AngIOgraphy IN Daily Practice in 2017 (PROTECTION VI), has been described previously. 16 The dose survey is an international, industryindependent, multi-vendor, prospective, observational study. With the objective to garner a representative worldwide sampling, a total of 435 clinicians from 62 different countries were invited as identified by literature research and by membership of the Society of Cardiovascular Computed Tomography (SCCT). The study collaborators enrolled all consecutive patients undergoing cardiac CTAs during one month between March and December 2017. Computed tomography studies before transfemoral aortic valve replacements were excluded, due to necessity to image the entire aorta and the heterogeneity in acquisition protocols. Cardiac CTAs were carried out according to local standard of clinical care. Data was analysed in a central core laboratory. Each study site consulted the responsible local ethics committee to evaluate the study protocol, which had to be approved prior to patient enrolment. All patients gave written informed consent as required at the individual study sites and data was obtained prospectively. An Executive Steering Committee composed of a group of physicians with expertise in cardiac CTA, clinical research and statistics supervised the study. The study has been registered with clinicaltrials.gov (NCT02996903).
Strategies for reduction of radiation dose
The selection of strategies for radiation dose reduction was at the discretion of the local study investigators. The conventional retrospectively electrocardiogram (ECG)-gated helical scan protocol is a robust scan technique, which is least radiation efficient. Prospectively ECG-triggered scan techniques, including the axial and high-pitch scan modes, deliver the radiation efficiently only during a short fraction of the R-R interval and is recommended for patients with sinus rhythm and heart rates < _65 b.p.m. 11 Reducing the tube potential from the conventionally used 120 kVp to 100 kVp lowers radiation exposure without compromising diagnostic image quality and has been recommended for patients with a body mass index (BMI) < _30 kg/m 2 . 12 The combination of iterative image reconstruction (IR) with reduced radiation tube currents has also been shown to reduce radiation exposure during coronary CTA without compromising diagnostic image quality. 10 
Estimation of radiation dose
The parameters relevant to radiation dose were obtained from the dose report generated by the CT system after each cardiac CTA study. The total dose-length product (DLP), which includes the radiation exposure of the entire CT investigation including among others the localizer and timing bolus, was the main outcome measure. The DLP CTA represents the radiation exposure, which was delivered for the acquisition of the CT angiography only. The DLP equals the CT dose index (CTDI vol ) multiplied by the respective scan length.
Image quality
Diagnostic image quality of coronary CTAs was assessed by the local investigators. Non-diagnostic image quality was defined by severe vessel blurring or vessel discontinuity secondary to reconstruction artefacts, which did not allow the exclusion of obstructive coronary lesions. Coronary CTAs were considered as non-diagnostic when at least one coronary artery was of non-diagnostic image quality.
Statistical analysis
Variables are expressed as counts with percentages or medians with interquartile ranges (IQRs ). Ninety percent of patients (4055 patients) were examined in sinus rhythm and beta blockers were administered in 66% (2973 patients) resulting in a median heart rate of 60 b.p.m. (IQR 55-67 b.p.m.).
The main indication for cardiac CTA was the evaluation of the coronary arteries (coronary CTA) in 89% of patients. Planning of electrophysiological procedures (4%) and visualization of bypass grafts (3%) were less frequent indications. All four major CT manufacturers were represented with examination of at least 13% of the enrolled patients. At the time of data collection modern CT scanners were used in both surveys with 96% and 91% of scans performed 64-slice and > _128-slice CT scanners in the 2007 and 2017 dose surveys, respectively.
Radiation dose
The median total DLP of all 4502 patients included in the 2017 dose survey was 252 mGy*cm (IQR 154-412 mGy*cm). The median total DLP for coronary CTAs was 246 mGy*cm (IQR 153-402 mGy*cm) with 79% of the radiation exposure resulting from the coronary CTA (DLP CTA 195 mGy*cm, IQR 110-338 mGy*cm, Table 2 ). The observed DLP of 195 mGy*cm corresponds to effective doses of 2.7 or 5.1 mSv, estimated using the thoracic or the recently published cardiac DLP to effective dose conversion factor of 0.014 or 0.026 mSv/mGy*cm, respectively. 17, 18 Compared with the 2007 survey, a significant 78% reduction in DLP CTA was observed in 2017 (P < 0.001). The regional development of radiation exposure from 2007 to 2017 is presented in Table 2 . Take home figure summarizes the reduction in radiation dose and the variability of DLP CTA between study sites in the 2007 and 2017 dose surveys. While a seven-fold difference was observed in the 2007 dose survey between the study sites with lowest and highest median DLP CTA (lowest and highest DLP CTA in 2007: 331 and 2146 mGy*cm, respectively), this dose variability increased to a 37-fold difference in the 2017 dose survey (lowest and highest median DLP CTA in 2017: 57 and 2090 mGy*cm, respectively). DLP CTA data stratified for gender and CT manufacturer are displayed in Figure 1 (further stratification according to CT model is given in Supplementary material online, Figure S1 ).
Compared with the 2007 dose survey, the reduction in radiation dose did not increase the rate of non-diagnostic CTA studies in 2017. The rates of non-diagnostic coronary CTAs were 1.7% and 1.9% in 2007 and 2017, respectively (P = 0.55).
Use of dose saving strategies
The relationship between radiation tube potential and DLP CTA is displayed in Figure 2A . Considering the cohorts of both surveys, the use of a tube potential of < _100 kVp increased significantly from 5% to 56% in the 2007 and 2017 surveys. When a BMI threshold of < _30 kg/ m 2 is considered for the eligibility of a < _100 kVp tube potential, 6%
and 70% of eligible patients were studied with a < _100 kVp scan protocol in the 2007 and 2017 dose surveys, respectively. A tube potential of less than 100 kVp, which has not been used in 2007, was applied in 14% of patients in 2017.
In the 2007 dose survey, 94% of patients were scanned using retrospectively ECG-gated helical imaging and only 6% of patients were examined by prospectively ECG-triggered axial imaging. In the 2017 dose survey, retrospective helical imaging was decreasingly utilized in only 11% of patients and prospectively ECG-triggered axial scanning was favoured in 78% of patients. ECG-triggered high-pitch helical imaging, which is available on dual-source CT systems, was applied in 11%. Compared with retrospectively ECG-gated helical scanning, the prospectively ECG-triggered scan modes (axial or high-pitch) resulted in a 74% reduction in radiation dose in the 2017 dose survey (P < 0.001; Figure 2B ). Image reconstruction methods, which were not available in 2007, were used in 83% of patients in the 2017. Application of IR techniques resulted in a 33% reduction of radiation dose, when compared with standard filtered back projection (P < 0.001, Figure 2C ).
Predictors for radiation dose
In the multivariable linear regression model, three patient-related and three scan-related variables of a total of 11 included parameters (see Supplementary material online, Table S2 ) were identified as independent predictors associated with radiation dose of coronary CTA. An increase in body weight of 10 kg, an increase in heart rate of 10 b.p.m., and the absence of sinus rhythm were associated with an increase of radiation dose of 7%, 8%, and 21%, respectively (all P < 0.01; Figure 3) . A decrease in the tube potential of 10 kVp and the use of IR were associated with a dose reduction of 21% and 30%, respectively (both P < 0.01). Finally, the use of the ECG-gated low-pitch helical scan technique resulted in an increase of radiation dose by 313% (P < 0.001), while the use of the ECG-triggered high-pitch scan technique was associated with 30% dose reduction (P = 0.08) when compared with the axial scan technique. The results were confirmed in a second logistic regression model, which addressed the performance to the proposed diagnostic reference level (see also Discussion section and Supplementary material online, Table S3 ).
Discussion
Cardiovascular CT has become an established and increasingly used technique mainly for the diagnostic assessment of CAD burden in patients with chest pain. Although several studies have evaluated strategies to reduce the radiation exposure of cardiac CT imaging, there is still concern about the delivered dose in daily practice. The current international dose survey demonstrates that the radiation exposure associated with cardiovascular CT has been tremendously reduced by 78% over the last decade. This progress contributed to the establishment of cardiac CT as frequently used non-invasive imaging method supported by national guidelines. 19 The determined international median DLP of coronary CTA corresponds to a recent national dose survey performed in the UK. 20 The achieved dose reduction can be attributed to several important factors: (i) the increasing awareness about radiation safety and the growing experience and knowledge of CT imagers in cardiovascular CT, (ii) the publication and (iii) the availability of scan protocols in modern CT scanners, which are radiation dose efficient. Scan protocols with a reduced tube potential and prospectively ECG-triggered scan protocols were, among others, the main contributor to the reduced radiation exposure in the 2017 dose survey. The use of 100 kVp instead of the conventional 120 kVp scan protocols in non-obese patients has been shown to reduce radiation exposure by 29% in a randomized comparison without compromising diagnostic image quality. 12 Over the last decade, the frequency of use of < _100 kVp scan protocols has raised by over 10-fold from 5% in 2007 to 56% in 2017. Similarly, the use of prospectively ECGtriggered scan modes has shown to reduce radiation exposure by at least 69% without compromising diagnostic image quality. 11, 21 These prospectively triggered scan modes were applied in 89% of patients undergoing coronary CTA in 2017, while the frequency was only 6% in 2007. The observed low median DLP CTA of 195 mGy*cm for a coronary CTA corresponds to an effective dose estimate of 2.7 or 5.1 mSv depending on the applied conversion factor (k = 0.014 or 0.026 mSv/mGy*cm). 17, 18 The effective dose estimates of coronary CTA are considerably lower than the recently published median effective dose estimates of 10.0 mSv for myocardial perfusion imaging, obtained from a comparable worldwide dose survey. 22 This difference may result in an improvement in population safety, if coronary CTA would be preferably used over myocardial perfusion imaging in patients with suspected CAD. The current dose survey allow for the determination of a new diagnostic reference level for coronary CTA. The diagnostic reference level, which is typically set at the 75th percentile dose level for a typical-sized patient and for a certain radiological procedure, is not the recommended or preferred dose, but rather an action level at which additional investigation into the dose used should be performed. Based on the current results, a new diagnostic reference level of 400 mGy*cm should be considered for coronary CTA. In 2017, median DLPs for coronary CTA were above this proposed diagnostic reference level in 13 of 61 participating centres (see Supplementary material online, Figure S2 ). This observation but even more the 37-fold difference in median DLPs between the study sites with the lowest and highest median DLPs underlines the need and potential for further education around dose reduction strategies and standardization of coronary CTA scan protocols. Considering the 89% use of prospectively ECG-triggered scan protocols (axial or high-pitch) in the current survey, a further increase in use will be difficult to achieve, when the presence of a stable sinus rhythm and a heart rate of < _65 b.p.m. are respected as selection criteria. In contrast, a scan protocol with < _100 kVp tube potential was selected in 'only' 70% of eligible patients, if a conservative BMI threshold of < _30 kg/m 2 was considered as eligibility criterion. Although this rate increased considerably from 2007 to 2017, this also indicates, that another 30% of patients with a BMI of < _30 kg/m 2 would have qualified for this dose saving scan protocol. A tube potential of 100 kVp has been successfully applied in some studies in patients up to a body weight of even 100 kg without compromising image quality. 23 If this body weight threshold would have been exploited as eligibility criterion, then even 36% of patients from the 2017 dose survey would have qualified for a low-dose 100 kVp scan protocol. Finally, scan protocols with tube potentials less than 100 kVp have demonstrated a large potential for further dose reductions, 24 but they have been used only in 14% of patients in the current dose survey. The results of the 2017 dose survey for cardiovascular CT have relevant implications on different levels of our health systems: On a patient level, the radiation doses should not discourage patients from undergoing coronary CTAs, when clinically indicated. In fact, an effective dose of 5 mSv in a 60-year-old patient (median age in the current survey) adds only a small, negligible additional risk to life-time cancer risk, but the diagnostic information and the clinical consequences resulting from a coronary CTA may outweigh this very small theoretical additional cancer risk. This becomes even more evident when the 0.05% estimated risk of fatal malignancy from a 10 mSv CT scan is compared with the 50% reduction in fatal and non-fatal myocardial reduction observed already 3 years after a coronary CTA. 5, 25 However, the large variability in radiation doses between participating study sites indicates that patients may select certified non-invasive imaging centres for their CT studies, because the likelihood of obtaining low-dose CT studies might be higher in certified than non-certified imaging centres. On a physician and institutional level, a continuous monitoring of patient's radiation exposure as well as the participation in dose surveys 20, 26 will allow for benchmarking with other physicians and institutions. The participation in such programmes has been shown to improve 'best practice' performance. 26 On a societal level, the 2017 radiation survey reveals the importance of education. The publication of guidelines as well as the organization of educational sessions on radiation exposure will improve the adherence to best practice recommendations. 27 Finally, on an industry level, the current study results claim for the set-up of default scan protocols, which are dose-efficient, as well as the development of applications supporting the automated selection of optimal low-dose scan parameters, which will secure low-dose cardiac imaging for the individual patient.
Limitations
The lack of financial support for study conduction allowed the gathering of data without bias, but limited also the participation of additional sites.
Conclusion
In conclusion, the 2017 radiation dose survey demonstrates that the radiation exposure from cardiac CTA has been considerably reduced over the last 10 years. This was accomplished by an increased use of (i) low tube potential scan protocols, (ii) prospectively ECG-triggered axial and high-pitch scan protocols, and (iii) iterative image reconstruction. However, a large 37-fold inter-site variability in median radiation dose was observed, which underlines the need for further site-specific training and adaptation of contemporary cardiac scan protocols. Reduction in radiation exposure in cardiovascular CT imaging
